0001562180-16-003206.txt : 20161004
0001562180-16-003206.hdr.sgml : 20161004
20161004161212
ACCESSION NUMBER: 0001562180-16-003206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161001
FILED AS OF DATE: 20161004
DATE AS OF CHANGE: 20161004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hadas Nicole R.
CENTRAL INDEX KEY: 0001602396
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 161918968
MAIL ADDRESS:
STREET 1: 20 PILGRAM DRIVE
CITY: WINCHESTER
STATE: MA
ZIP: 01890
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-10-01
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001602396
Hadas Nicole R.
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
SVP, General Counsel, Sec.
Common Stock
2016-10-01
4
S
false
1556.00
8.9548
D
83915.00
D
Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through December 2, 2017.
John P. Butler, Attorney-in-Fact for Nicole R. Hadas
2016-10-04